
Eastman Chemical (EMN) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
2.3B
Gross Profit
567.0M
24.76%
Operating Income
318.0M
13.89%
Net Income
183.0M
7.99%
EPS (Diluted)
$1.57
Balance Sheet Metrics
Total Assets
15.0B
Total Liabilities
9.0B
Shareholders Equity
5.9B
Debt to Equity
1.52
Cash Flow Metrics
Operating Cash Flow
-167.0M
Free Cash Flow
-314.0M
Revenue & Profitability Trend
Eastman Chemical Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 9.4B | 9.2B | 10.6B | 10.5B | 8.5B |
Cost of Goods Sold | 7.1B | 7.1B | 8.4B | 8.0B | 6.5B |
Gross Profit | 2.3B | 2.1B | 2.1B | 2.5B | 2.0B |
Gross Margin % | 24.4% | 22.4% | 20.2% | 23.9% | 23.3% |
Operating Expenses | |||||
Research & Development | 250.0M | 239.0M | 264.0M | 254.0M | 226.0M |
Selling, General & Administrative | 664.0M | 768.0M | 625.0M | 383.0M | 654.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 914.0M | 1.0B | 889.0M | 637.0M | 880.0M |
Operating Income | 1.4B | 1.1B | 1.2B | 1.9B | 1.1B |
Operating Margin % | 14.7% | 11.4% | 11.8% | 17.8% | 12.9% |
Non-Operating Items | |||||
Interest Income | 16.0M | 10.0M | 6.0M | 3.0M | 4.0M |
Interest Expense | 216.0M | 225.0M | 188.0M | 198.0M | 210.0M |
Other Non-Operating Income | -98.0M | 248.0M | -89.0M | -583.0M | -355.0M |
Pre-tax Income | 1.1B | 1.1B | 977.0M | 1.1B | 530.0M |
Income Tax | 170.0M | 191.0M | 181.0M | 215.0M | 41.0M |
Effective Tax Rate % | 15.8% | 17.6% | 18.5% | 19.9% | 7.7% |
Net Income | 908.0M | 896.0M | 796.0M | 867.0M | 489.0M |
Net Margin % | 9.7% | 9.7% | 7.5% | 8.3% | 5.8% |
Key Metrics | |||||
EBITDA | 1.9B | 1.5B | 1.7B | 2.4B | 1.5B |
EPS (Basic) | $7.75 | $7.54 | $6.42 | $6.35 | $3.53 |
EPS (Diluted) | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 |
Basic Shares Outstanding | 116700000 | 118600000 | 123500000 | 134900000 | 135500000 |
Diluted Shares Outstanding | 116700000 | 118600000 | 123500000 | 134900000 | 135500000 |
Income Statement Trend
Eastman Chemical Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 837.0M | 548.0M | 493.0M | 459.0M | 564.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 791.0M | 826.0M | 957.0M | 1.1B | 1.0B |
Inventory | 2.0B | 1.7B | 1.9B | 1.5B | 1.4B |
Other Current Assets | 104.0M | 96.0M | 114.0M | 96.0M | 83.0M |
Total Current Assets | 4.1B | 3.5B | 3.8B | 4.6B | 3.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 8.3B | 8.4B | 8.5B | 8.6B | 10.7B |
Intangible Assets | 1.0B | 1.1B | 1.2B | 1.4B | 1.8B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 833.0M | 820.0M | 855.0M | 874.0M | 736.0M |
Total Non-Current Assets | 11.1B | 11.2B | 10.9B | 10.9B | 12.5B |
Total Assets | 15.2B | 14.6B | 14.7B | 15.5B | 16.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.3B | 1.2B | 1.3B | 1.2B | 799.0M |
Short-term Debt | 450.0M | 541.0M | 1.1B | 747.0M | 349.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 428.0M | 270.0M | 288.0M | 376.0M | 252.0M |
Total Current Liabilities | 2.7B | 2.6B | 3.3B | 3.0B | 2.0B |
Non-Current Liabilities | |||||
Long-term Debt | 4.6B | 4.3B | 4.0B | 4.4B | 5.3B |
Deferred Tax Liabilities | 533.0M | 601.0M | 671.0M | 810.0M | 848.0M |
Other Non-Current Liabilities | 923.0M | 954.0M | 856.0M | 727.0M | 677.0M |
Total Non-Current Liabilities | 6.7B | 6.5B | 6.2B | 6.8B | 7.9B |
Total Liabilities | 9.4B | 9.1B | 9.4B | 9.7B | 10.0B |
Equity | |||||
Common Stock | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
Retained Earnings | 10.0B | 9.5B | 9.0B | 8.6B | 8.1B |
Treasury Stock | 6.4B | 6.1B | 5.9B | 4.9B | 4.0B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 5.9B | 5.5B | 5.2B | 5.8B | 6.1B |
Key Metrics | |||||
Total Debt | 5.0B | 4.8B | 5.2B | 5.2B | 5.6B |
Working Capital | 1.4B | 905.0M | 527.0M | 1.7B | 1.5B |
Balance Sheet Composition
Eastman Chemical Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 908.0M | 896.0M | 796.0M | 867.0M | 489.0M |
Depreciation & Amortization | 509.0M | 498.0M | 477.0M | 538.0M | 574.0M |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -77.0M | 291.0M | 13.0M | -27.0M | 165.0M |
Operating Cash Flow | 1.3B | 1.7B | 898.0M | 1.3B | 1.1B |
Investing Activities | |||||
Capital Expenditures | -599.0M | -828.0M | -611.0M | -555.0M | -383.0M |
Acquisitions | 38.0M | 379.0M | 997.0M | 553.0M | -1.0M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -534.0M | -427.0M | 405.0M | -6.0M | -381.0M |
Financing Activities | |||||
Share Repurchases | -300.0M | -150.0M | -1.0B | -1.0B | -60.0M |
Dividends Paid | -379.0M | -376.0M | -381.0M | -375.0M | -358.0M |
Debt Issuance | 1.2B | 796.0M | 500.0M | 0 | 249.0M |
Debt Repayment | -1.0B | -808.0M | -750.0M | -300.0M | -435.0M |
Financing Cash Flow | -454.0M | -888.0M | -1.3B | -1.7B | -704.0M |
Free Cash Flow | 688.0M | 541.0M | 351.0M | 1.0B | 1.1B |
Net Change in Cash | 348.0M | 344.0M | -18.0M | -379.0M | -17.0M |
Cash Flow Trend
Eastman Chemical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
9.29
Forward P/E
7.59
Price to Book
1.30
Price to Sales
0.82
PEG Ratio
-0.25
Profitability Ratios
Profit Margin
8.96%
Operating Margin
12.42%
Return on Equity
14.39%
Return on Assets
5.54%
Financial Health
Current Ratio
1.68
Debt to Equity
90.60
Beta
1.23
Per Share Data
EPS (TTM)
$7.11
Book Value per Share
$50.84
Revenue per Share
$80.36
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
emn | 7.6B | 9.29 | 1.30 | 14.39% | 8.96% | 90.60 |
Linde plc | 222.6B | 34.37 | 5.86 | 17.01% | 20.02% | 60.56 |
Sherwin-Williams | 91.5B | 36.39 | 20.70 | 62.43% | 11.03% | 308.57 |
Albemarle | 9.9B | 33.52 | 1.26 | -9.99% | -22.39% | 35.76 |
NewMarket | 7.4B | 15.62 | 4.60 | 33.74% | 17.28% | 56.98 |
Axalta Coating | 6.7B | 15.23 | 2.97 | 21.70% | 8.58% | 147.77 |
Financial data is updated regularly. All figures are in the company's reporting currency.